Open Text to Showcase Leading Life Sciences Solutions at the Drug Information Association (DIA) Meeting in Atlanta
Solutions Built to Address Specific Market Needs; Support Essential Critical Processes for the Compliant Management of All Paper and Electronic Records and Documents
Chicago, IL - 2007-06-11 - Open Text Corporation (NASDAQ: OTEX, TSX: OTC), the largest independent provider of enterprise content management (ECM) software and solutions, today announced that it will showcase its industry-leading solutions for pharmaceutical and life sciences companies at the 2007 Drug Information Association (DIA) Meeting to be held in Atlanta, Georgia, June 17 - 21 at the Georgia World Congress Center. Open Text will demonstrate its industry specific applications at booth #115.
Open Text is a leader in providing enterprise content management solutions to pharmaceutical and biotechnology companies, contract research organizations and medical device manufacturers. Open Text s industry specific applications for life sciences include solutions for regulatory content and submissions management, quality management, and clinical trials. Other business related applications Open Text is helping pharmaceutical and biotechnology organizations with include: internal controls, contract management and litigation support, email management, records management, Web content management, and ERP/CRM archiving.
At booth #115, Open Text will showcase the following solutions:
- Regulated Documents for Microsoft Office SharePoint Server 2007, which builds on Open Text s experience from its successful Livelink ECM Regulated Documents solution, first introduced to life sciences companies in 2002. The solution extends Open Text s extensive and well-proven life sciences domain knowledge to a new ECM platform. The solution will allow companies to use 2007 Microsoft Office applications to manage, author, review and approve content in a controlled environment that is compliant with specific U.S. Food and Drug Administration (FDA) guidelines, such as the 21 CFR Part 11 regulations.
- Livelink ECM Quality Management System, which provides a fully integrated solution that complies with the electronic records provisions of the FDA s 21 CFR Part 11, while addressing the needs for Pharmaceutical Best Practice (21 CFR 210 and 211), Biological Best Practice (21 CFR 600-680) and Medical Device Best Practice (21 CFR 820). The system is a flexible and expandable solution that integrates the key processes required for life sciences organizations, including Audit, Training, and Regulated Document Management into an enterprise-level solution.
- Livelink ECM - Collaborative Submissions, which is designed to help companies manage the assembly, review, approval and release of large document submissions that are made to government regulatory bodies responsible for drugs, biologics and related products. The comprehensive solution drastically reduces time to market by enabling companies to prepare and make submissions in the industry s eCTD (Electronic Common Technical Document) format. eCTD submissions can contain thousands of documents which have to be carefully managed through their respective lifecycles. Each submission in turn is part of an overall product application that requires updates, amendments and follow-on submissions.
For more information on the full range of Open Text pharmaceutical and life sciences solutions go to: www.opentext.com/2/sol-industry/sol-ind-pharma.htm
For more information about the DIA s 43rd Annual Meeting, go to: www.diahome.org/DIAHome/FlagshipMeetings/home.aspx?meetingid=11362
About Open Text
Open Text is the world's largest independent provider of Enterprise Content Management software. The Company's solutions manage information for all types of business, compliance and industry requirements in the world's largest companies, government agencies and professional service firms. Open Text supports approximately 46,000 customers and millions of users in 114 countries and 12 languages. For more information about Open Text, visit www.opentext.com.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995
This news release may contain forward-looking statements relating to the success of any of the Company s strategic initiatives, the Company s growth and profitability prospects, the benefits of the Company s products to be realized by customers, the Company s position in the market and future opportunities therein, the deployment of Livelink and our other products by customers, and future performance of Open Text Corporation. Forward-looking statements may also include, without limitation, any statement relating to future events, conditions or circumstances. Forward-looking statements in this release are not promises or guarantees and are subject to certain risks and uncertainties, and actual results may differ materially. The risks and uncertainties that may affect forward-looking statements include, among others, the failure to develop new products, risks involved in fluctuations in currency exchange rates, delays in purchasing decisions of customers, the completion and integration of acquisitions, the possibility of technical, logistical or planning issues in connection with deployments, the continuous commitment of the Company's customers, demand for the Company's products and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), including the Form 10-K for the year ended June 30, 2006. You should not place undue reliance upon any such forward-looking statements, which are based on management's beliefs and opinions at the time the statements are made, and the Company does not undertake any obligations to update forward-looking statements should circumstances or management's beliefs or opinions change.
Copyright © 2007 by Open Text Corporation. LIVELINK ECM and OPEN TEXT are trademarks or registered trademarks of Open Text Corporation in the United States of America, Canada, the European Union and/or other countries. This list of trademarks is not exhaustive. Other trademarks, registered trademarks, product names, company names, brands and service names mentioned herein are property of Open Text Corporation or other respective owners.
For more information, please contact
Richard Maganini
Open Text Corporation
1-847-961-0662
rmaganin@opentext.com
Brian Edwards
McKenzie Worldwide
+1-503-577-4583
briane@mckenzieworldwide.com
Michele Stevenson
Open Text Corporation
519-888-7111 ext. 2594
mstevens@opentext.com
